Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
boston blog main
boston top stories
life sciences
national blog main
biotech
drugs
national top stories
sickle cell disease
aldehyde
aldeyra therapeutics
allergic conjunctivitis
azacitidine
beta-thalassemia
clinical trials
crispr
cystic fibrosis
cystic fibrosis foundation
dacogen
deals
decitabine
dna
dry eye disease
epigenetics
epizyme
farydak
fda
flagship pioneering
fulcrum therapeutics
gilead sciences
hepatitis c
incivek
insulated genomic domains
jeff leiden
kaleido biosciences
kayldeco
mahesh karande
matt emmens
messenger rna therapeutics
new york blog main
What
step
3
×
medicines
new
therapeutics
aims
aldeyra
approach
based
biotech
called
cf
closer
crisis
cystic
data
debuts
developer
developing
disclosed
drug
drugs
epigenetic
epigenetics
eye
fda
fibrosis
field
fighting
filing
flagship’s
force
helped
inflammation
jeff
leiden
medicine
morning
multiple
omega
pharmaceuticals
Language
unknown
unset
Current search:
step
×
boston
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug